Biospecific interaction analysis (BIA) of low-molecular weight DNA- binding drugs

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 1, 2000, Pages 370-377

  Gambari, Roberto ^a   Feriotto, Giordana ^a   Rutigliano, Cristina ^a   Bianchi, Nicoletta ^a   Mischiati, Carlo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; CHROMOMYCIN; DISTAMYCIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEN 10567; MITHRAMYCIN; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; BIOSENSOR; DNA SEQUENCE; DRUG ACTIVITY; DRUG BINDING SITE; DRUG DNA BINDING; GENETIC TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR INTERACTION; MOLECULAR STABILITY; NEOPLASM; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; TATA BOX; VIRUS INFECTION;

BIOSENSING TECHNIQUES; CHROMOMYCINS; DISTAMYCINS; DNA; MOLECULAR WEIGHT; PLICAMYCIN;

EID: 0033932507     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bellorini M, Moncollin V, D'incalci M, Mongelli N and Mantovani R (1995) Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription. Nucleic Acids Res 23:1657-1663.
2. Bianchi N, Passadore M, Rutigliano C, Feriotto G, Mischiati C and Gambari R (1996) Targeting of the Sp1 binding sites of HIV-1 long terminal repeat with chromomycin. Biochem Pharmacol 52:1489-1498.
3. Broggini M, Ponti M, Ottolenghi S, D'incalci M, Mongelli N and Mantovani R (1989) Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements. Nucleic Acids Res 17:1051-1061.
4. Chen X, Ramakrishnan B and Sundaralingam M (1997) Crystal structures of the side-by-side binding of distamycin to AT-containing DNA octamers d(ICITACIC) and d(ICATATIC). J Mol Biol 267:1157-1170.
5. Chiang SY, Welch J, Rausher FJ and Beerman TA (1994) Effects of minor groove binding drugs on the interaction of TATA box binding protein and TFIIA with DNA. Biochemistry 33:7033-7040.
6. Churchill MEA, Hayes JJ and Tullius TD (1990) Detection of drug binding to DNA by hydroxyl radical footprinting. Relationship of distamycin binding sites to DNA structure and positioned nucleosomes of 5S RNA genes of Xenopus. Biochemistry 29:6043-6050.
7. Dervan PB (1986) Design of sequence-specific DNA binding molecules. Science (Wash DC) 232:464-471.
8. Dorn A, Affolter M, Muller M, Gehring WJ and Leupin W (1992) Distamycin-induced inhibition of homeodomain-DNA complexes. EMBO J 11:279-286.
9. Feriotto G, Ciucci A, Mischiati C, Animati F, Lombardi P, Giacomini P and Gambari R (1994a) Binding of Epstein-Barr virus nuclear antigen 1 to DNA: Inhibition by distamycin and two novel distamycin analogues. Eur J Pharmacol 267:143-149.
10. Feriotto G, Mischiati C and Gambari R (1994b) Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: A DNase I footprinting study. Biochem J 299:451-458.
11. Fox KR, Sansom CE and Stevens MF (1990) Footprinting studies on the sequence-selective binding of pentamidine to DNA. FEBS Lett 266:150-154.
12. Gambari R and Nastruzzi C (1994) DNA-binding activity and biological effects of aromatic polyamidines. Biochem Pharmacol 47:599-610.
13. Gambari R, Barbieri R, Nastruzzi C, Chiorboli V, Feriotto G and Natali PG (1991) Distamycin inhibits the binding of a nuclear factor to the -278/-256 upstream sequence of the human HLA-DRα gene. Biochem Pharmacol 41:495-502.
14. Gao X, Mirau P and Patel DJ (1992) Structure refinement of the chromomycin-DNA oligomer complex in solution. J Mol Biol 248:259-279.
15. Jonsson U, Fagerstam L, Ivarsson B, Johnsson B and Karlsson R (1991) Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques 11:620-627.
16. Karlsson R and Stahlberg R (1995) Surface plasmon resonance detection and multispot sensing for direct monitoring of interactions involving low-molecular-weight analytes and for determination of low affinities. Anal Biochem 228:274-280.
17. Laughton CA, Jenkins TC, Fox KR and Neidle S (1990) Interaction of berenil with the tyrT DNA sequence studied by footprinting and molecular modelling. Implications for the design of sequence-specific DNA recognition agents. Nucleic Acids Res 18:4479-4488.
18. Malmqvist M (1993) Biospecific interactions analysis using biosensor technology. Nature (Lond) 361:186-187.
19. Montecucco A, Fontana M, Focher F, Lestingi M, Spadari S and Ciarrocchi G (1991) Specific inhibition of human DNA ligase adenylation by a distamycin derivative possessing antitumor activity. Nucleic Acids Res 19:1067-1072.
20. Nilsson P, Persson B, Uhlén M and Nygren PA (1995) Real-time monitoring of DNA manipulations using biosensor technology. Anal Biochem 224:400-408.
21. Passadore M, Bianchi N, Feriotto G, Mischiati C, Giacomini P, Piva R and Gambari R (1995) Differential effects of distamycin analogues on amplification of human gene sequences by polymerase-chain reaction. Biochem J 308:513-519.
22. Passadore M, Feriotto G, Bianchi N, Aguiari G, Mischiati C, Piva R and Gambari R (1994) Polymerase-chain reaction as a tool for investigations on sequence-selectivity of DNA-drugs interactions. J Biochem Biophys Methods 29:307.
23. Portugal J and Waring MJ (1987) Hydroxyl radical footprinting of the sequence-selective binding of netropsin and distamycin to DNA. FEBS Lett 225:195-200.
24. Sastry M, Fiala R and Patel DJ (1995) Solution structure of mithramycin dimers bound to partially overlapping sites on DNA. J Mol Biol 251:674-689.
25. Snyder RC, Ray R, Blume S and Miller D (1991) Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry 30:4290-4297.
26. Vadgama P and Crump PW (1992) Biosensors: Recent trends, a review. Analyst 117:1657-1670.
27. Van Dyke WW and Dervan PB (1983) Chromomycin, mithramycin and olivomycin binding sites on heterogeneous deoxyribonucleic acid. Footprinting with (methidiumpropyl-EDTA)iron(II). Biochemistry 22:2373-2377.
28. Vaquero A and Portugal J (1998) Modulation of DNA-protein interactions in the P1 and P2 promoters by two intercalating drugs. Eur J Biochem 261:435-442.
29. Welch JJ, Rausher Iii FJ and Beerman TA (1994) Targeting DNA-binding drugs to sequence-specific transcription factor: DNA complexes. J Biol Chem 269:31051-31058.
30. White RJ and Phillips DR (1989) Sequence-dependent termination of bacteriophage T7 transcription in vitro by DNA-binding drugs. Biochemistry 28:4277-4283.
31. Wood SJ (1993) DNA-DNA hybridization in real time using BIAcore. Microchem J 47:330-337.